Anthony Bunn
Corporate Secretary presso De Novo Pharmaceuticals Ltd.
Profilo
Anthony John Bunn is currently working as a Secretary at De Novo Pharmaceuticals Ltd.
He previously worked as a Secretary at Sareum Holdings Plc.
Posizioni attive di Anthony Bunn
| Società | Posizione | Inizio |
|---|---|---|
De Novo Pharmaceuticals Ltd.
 De Novo Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology De Novo Pharmaceuticals Ltd. discovers and develops drugs. It is a novel molecular structure generating drug discovery platform targeting pathogenic bacteria. The firm offers lower cost, rapid, lower molecular weights hits, novel, and patentable hit molecules. The company was founded by David Bailey, Iwan de Esch, and Philip Dean M on April 28, 1999 and is headquartered in London, the United Kingdom. | Corporate Secretary | 01/09/2000 |
Precedenti posizioni note di Anthony Bunn
| Società | Posizione | Fine |
|---|---|---|
| SAREUM HOLDINGS PLC | Corporate Secretary | 07/01/2022 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| SAREUM HOLDINGS PLC | Miscellaneous |
| Aziende private | 1 |
|---|---|
De Novo Pharmaceuticals Ltd.
De Novo Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology De Novo Pharmaceuticals Ltd. discovers and develops drugs. It is a novel molecular structure generating drug discovery platform targeting pathogenic bacteria. The firm offers lower cost, rapid, lower molecular weights hits, novel, and patentable hit molecules. The company was founded by David Bailey, Iwan de Esch, and Philip Dean M on April 28, 1999 and is headquartered in London, the United Kingdom. | Health Technology |
- Borsa valori
- Insiders
- Anthony Bunn
